Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CK-0045 by CytoKi Pharma for Inflammatory Bowel Disease: Likelihood of Approval
CK-0045 is under clinical development by CytoKi Pharma and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData,...
Data Insights
CK-0045 by CytoKi Pharma for Obesity: Likelihood of Approval
CK-0045 is under clinical development by CytoKi Pharma and currently in Phase II for Obesity. According to GlobalData, Phase II...